San Diego Biotech News

• Epic Sciences Comprehensive Cancer Profiling Platform Shows Compelling Value Of Cell Analysis In Data Presented At ESMO Congress 2021

  September 18, 2021 Comments Off on Epic Sciences Comprehensive Cancer Profiling Platform Shows Compelling Value Of Cell Analysis In Data Presented At ESMO Congress 2021
• BioFluidica Announces Commercialization of its High Throughput LiquidScan™ Automated Liquid Biopsy System for Capturing Rare Biomarkers on a Single Scalable Platform.

  September 17, 2021 Comments Off on BioFluidica Announces Commercialization of its High Throughput LiquidScan™ Automated Liquid Biopsy System for Capturing Rare Biomarkers on a Single Scalable Platform.
• A Pfizer partner welcomes ex-ADC Therapeutics CMO Jay Feingold to the team; Amid tough sledding, Immunovant chooses Eli Lilly alum as CFO

  September 17, 2021 Comments Off on A Pfizer partner welcomes ex-ADC Therapeutics CMO Jay Feingold to the team; Amid tough sledding, Immunovant chooses Eli Lilly alum as CFO
• San Diego biotech allies warn drug pricing bill stifles cures. Critics don’t buy it

  September 16, 2021 Comments Off on San Diego biotech allies warn drug pricing bill stifles cures. Critics don’t buy it
• eFFECTOR Therapeutics to Participate in 2021 Cantor Virtual Healthcare Conference

  September 16, 2021 Comments Off on eFFECTOR Therapeutics to Participate in 2021 Cantor Virtual Healthcare Conference
• Dalrada Corporation’s Pala Diagnostics Free COVID-19 Point-of-care Tests Proved Compliance for Nearly 3,000 Outdoor Festival Attendees

  September 16, 2021 Comments Off on Dalrada Corporation’s Pala Diagnostics Free COVID-19 Point-of-care Tests Proved Compliance for Nearly 3,000 Outdoor Festival Attendees
• Endeavor Biomedicines licenses ULK1/2 inhibitor from Sanford Burnham Prebys and the Salk Institute

  September 16, 2021 Comments Off on Endeavor Biomedicines licenses ULK1/2 inhibitor from Sanford Burnham Prebys and the Salk Institute
• FDA accepts Intellia’s IND for CRISPR and TCR-T cell therapy; Santé closes Fund IV at $260M

  September 16, 2021 Comments Off on FDA accepts Intellia’s IND for CRISPR and TCR-T cell therapy; Santé closes Fund IV at $260M
• The Salk Institute and Sanford Burnham Prebys licenses ULK1/2 inhibitors to Endeavor BioMedicines for treatment of cancer

  September 16, 2021 Comments Off on The Salk Institute and Sanford Burnham Prebys licenses ULK1/2 inhibitors to Endeavor BioMedicines for treatment of cancer
• Cirrascale Cloud Services® and Cerebras Systems Announce Availability of Cerebras Cloud @ Cirrascale for Unparalleled Artificial Intelligence Performance

  September 16, 2021 Comments Off on Cirrascale Cloud Services® and Cerebras Systems Announce Availability of Cerebras Cloud @ Cirrascale for Unparalleled Artificial Intelligence Performance